Please use this identifier to cite or link to this item:
Title: Exploiting metabolic vulnerabilities of Non small cell lung carcinoma
Author: Majem, Blanca
Nadal, Ernest
Muñoz Pinedo, Cristina
Keywords: Càncer de pulmó
Lung cancer
Issue Date: 1-Feb-2020
Publisher: Elsevier BV
Abstract: Lung cancer is the main cause of cancer death worldwide. Non-Small Cell Lung Carcinoma (NSCLC) is the most common subtype of lung cancer, and the prognosis of NSCLC patients in advanced stages is still very poor. Given the need for new therapies, the metabolism of NSCLC has been widely studied in the past two decades to identify vulnerabilities that could be translated into novel anti-metabolic therapeutic approaches. A number of studies have highlighted the role of glucose and mitochondrial metabolism in the development of NSCLC. The metabolic properties of lung tumors have been characterized in detail in vivo, and they include high glucose and lactate use and high heterogeneity regarding the use of nutrients and mitochondrial pathways. This heterogeneity has also been observed in patients infused with labeled nutrients. We will summarize here the knowledge about the use of amino acids, fatty acids and carbohydrates in NSCLC that could lead to new combination treatments.
Note: Reproducció del document publicat a:
It is part of: Seminars in Cell & Developmental Biology, 2020, vol. 98, p. 54-62
Related resource:
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
1-s2.0-S1084952118301861-main.pdf3.32 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons